How much funding has Cagent Vascular raised?

Cagent Vascular has raised $86.0M in total funding, most recently a Series D round.

Who are Cagent Vascular's investors?

Cagent Vascular's investors include US Venture Partners, Trinity Ventures.

When was Cagent Vascular founded?

Cagent Vascular was founded in 2014.

Where is Cagent Vascular headquartered?

Cagent Vascular is headquartered in Wayne, Pennsylvania, United States.

What industry is Cagent Vascular in?

Cagent Vascular operates in Healthcare.

How many employees does Cagent Vascular have?

Cagent Vascular has 11-50 employees.

Cagent Vascular

Homepage

Wayne, United States · Founded 2014 · $86.0M raised

Healthcare

Headquarters: Wayne, Pennsylvania
Employees: 11–50
Founded: 2014
Business Model: B2B

Website: cagentvascular.com
Total Funding: $86.0M
Last Round: $41.0M Series DMay 2026
Rounds: 3

About

Cagent Vascular, founded in 2014 by Carol Burns and Robert Giasolli, develops next-generation angioplasty balloons using proprietary Serration Remodeling Therapy (SRT). The company's Serranator balloon is the first and only commercialized angioplasty device featuring integrated serrations, delivering predictable lumen gain and reduced recoil.

Summary

Cagent Vascular is a Healthcare company based in Wayne, United States, founded in 2014. It has raised $86.0M in total across 3 rounds, most recently a $41.0M Series D round in May 2026. Investors include US Venture Partners and Trinity Ventures.

LinkedIn X (Twitter)